PL339414A1 - Antagonistic vitronectin receptor - Google Patents
Antagonistic vitronectin receptorInfo
- Publication number
- PL339414A1 PL339414A1 PL98339414A PL33941498A PL339414A1 PL 339414 A1 PL339414 A1 PL 339414A1 PL 98339414 A PL98339414 A PL 98339414A PL 33941498 A PL33941498 A PL 33941498A PL 339414 A1 PL339414 A1 PL 339414A1
- Authority
- PL
- Poland
- Prior art keywords
- antagonistic
- vitronectin receptor
- vitronectin
- receptor
- antagonistic vitronectin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5986797P | 1997-09-24 | 1997-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL339414A1 true PL339414A1 (en) | 2000-12-18 |
Family
ID=22025805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98339414A PL339414A1 (en) | 1997-09-24 | 1998-09-24 | Antagonistic vitronectin receptor |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1023073A1 (en) |
| JP (1) | JP2002500162A (en) |
| KR (1) | KR20010024249A (en) |
| CN (1) | CN1271284A (en) |
| AU (1) | AU9578798A (en) |
| BR (1) | BR9813214A (en) |
| CA (1) | CA2304000A1 (en) |
| HU (1) | HUP0003931A2 (en) |
| IL (1) | IL135188A0 (en) |
| NO (1) | NO20001515D0 (en) |
| PL (1) | PL339414A1 (en) |
| TR (1) | TR200000786T2 (en) |
| WO (1) | WO1999015178A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000046215A1 (en) | 1999-02-03 | 2000-08-10 | Merck & Co., Inc. | Benzazepine derivatives as alpha-v integrin receptor antagonists |
| US6514964B1 (en) | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
| CN1247258C (en) | 2001-04-24 | 2006-03-29 | 默克专利有限公司 | Combination therapy using anti-angiogenic agents and tnfa |
| CN100560131C (en) | 2001-10-22 | 2009-11-18 | 斯克里普斯研究学院 | Antibody targeting compounds |
| JP2006522139A (en) | 2003-04-04 | 2006-09-28 | スミスクライン・ビーチャム・コーポレイション | Process for producing benzazepine and intermediates thereof |
| EP1711614B1 (en) | 2004-02-02 | 2009-01-07 | Pioneer Hi-Bred International, Inc. | Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| EP1973569B1 (en) | 2006-01-18 | 2013-05-22 | Merck Patent GmbH | Specific therapy using integrin ligands for treating cancer |
| US20100069302A1 (en) | 2007-07-18 | 2010-03-18 | Stefan Krueger | Specific therapy and medicament using integrin ligands for treating cancer |
| ES2428896T3 (en) | 2007-11-16 | 2013-11-12 | Ube Industries, Ltd. | Benzacepinone compound |
| EP2257538B1 (en) * | 2008-03-06 | 2016-04-27 | GlaxoSmithKline LLC | Process for the preparation of benzodiazepine derivatives |
| WO2010093706A2 (en) | 2009-02-10 | 2010-08-19 | The Scripps Research Institute | Chemically programmed vaccination |
| CN102427816A (en) | 2009-03-30 | 2012-04-25 | 宇部兴产株式会社 | Pharmaceutical composition for treatment or prevention of ophthalmic diseases |
| JP2012528079A (en) | 2009-05-25 | 2012-11-12 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Continuous administration of integrin ligand to treat cancer |
| EP2529017A2 (en) | 2009-12-30 | 2012-12-05 | Pioneer Hi-Bred International, Inc. | Methods and compositions for targeted polynucleotide modification |
| EP3078748B1 (en) | 2009-12-30 | 2021-08-11 | Pioneer Hi-Bred International, Inc. | Methods and compositions for the introduction and regulated expression of genes in plants |
| KR20160147007A (en) | 2014-05-30 | 2016-12-21 | 화이자 인코포레이티드 | Carbonitrile derivatives as selective androgen receptor modulators |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA60311C2 (en) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Vitronectin receptor antagonists |
-
1998
- 1998-09-24 TR TR2000/00786T patent/TR200000786T2/en unknown
- 1998-09-24 AU AU95787/98A patent/AU9578798A/en not_active Abandoned
- 1998-09-24 BR BR9813214-8A patent/BR9813214A/en not_active Application Discontinuation
- 1998-09-24 PL PL98339414A patent/PL339414A1/en unknown
- 1998-09-24 JP JP2000512547A patent/JP2002500162A/en not_active Withdrawn
- 1998-09-24 EP EP98949471A patent/EP1023073A1/en active Pending
- 1998-09-24 WO PCT/US1998/019987 patent/WO1999015178A1/en not_active Application Discontinuation
- 1998-09-24 CN CN98809494A patent/CN1271284A/en active Pending
- 1998-09-24 IL IL13518898A patent/IL135188A0/en unknown
- 1998-09-24 HU HU0003931A patent/HUP0003931A2/en unknown
- 1998-09-24 KR KR1020007003093A patent/KR20010024249A/en not_active Application Discontinuation
- 1998-09-24 CA CA002304000A patent/CA2304000A1/en not_active Abandoned
-
2000
- 2000-03-23 NO NO20001515A patent/NO20001515D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR200000786T2 (en) | 2000-08-21 |
| BR9813214A (en) | 2000-08-29 |
| HUP0003931A2 (en) | 2001-10-28 |
| EP1023073A1 (en) | 2000-08-02 |
| IL135188A0 (en) | 2001-05-20 |
| KR20010024249A (en) | 2001-03-26 |
| AU9578798A (en) | 1999-04-12 |
| NO20001515L (en) | 2000-03-23 |
| JP2002500162A (en) | 2002-01-08 |
| CA2304000A1 (en) | 1999-04-01 |
| WO1999015178A1 (en) | 1999-04-01 |
| NO20001515D0 (en) | 2000-03-23 |
| CN1271284A (en) | 2000-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL332674A1 (en) | Antagonistic receptor of vitronectin | |
| EP1000031A4 (en) | Vitronectin receptor antagonist | |
| EP1047425A4 (en) | Integrin receptor antagonists | |
| IL130760A0 (en) | Vitronectin receptor antagonists | |
| EP0767792A4 (en) | Vitronectin receptor antagonists | |
| ZA955391B (en) | Vitronectin receptor antagonists | |
| EP1007051A4 (en) | Integrin receptor antagonists | |
| PL339413A1 (en) | Antagonistic vitronectin receptor | |
| PL339414A1 (en) | Antagonistic vitronectin receptor | |
| IL135028A0 (en) | Vitronectin receptor antagonists | |
| PL342881A1 (en) | Vitronectin receptor antagonists | |
| EP1027337A4 (en) | Integrin receptor antagonists | |
| EG24025A (en) | Vitronectin receptor antagonist | |
| EP0973800A4 (en) | Novel receptor | |
| IL141163A0 (en) | Vitronectin receptor antagonists | |
| ZA988562B (en) | Vitronectin receptor antagonists | |
| SI0957917T1 (en) | Vitronectin receptor antagonists | |
| GB9810892D0 (en) | Vitronectin receptor antagonists | |
| GB9815803D0 (en) | Vitronectin receptor antagonists | |
| GB9812686D0 (en) | Vitronectin receptor antagonists | |
| GB9810882D0 (en) | Vitronectin receptor antagonists | |
| GB9810182D0 (en) | Vitronectin receptor antagonists | |
| GB9807384D0 (en) | Vitronectin receptor antagonists | |
| GB9807382D0 (en) | Vitronectin receptor antagonists | |
| GB9822331D0 (en) | Vitronectin receptor antagonists |